Stock-Based Compensation - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2026 |
Sep. 30, 2025 |
Sep. 30, 2026 |
Sep. 30, 2025 |
|
| Stock-Based Compensation | ||||
| Stock-based compensation expense | $ 2,346 | $ 2,526 | $ 7,143 | $ 7,635 |
| Employee Stock Option | ||||
| Stock-Based Compensation | ||||
| Intrinsic value of options per share (in $ per share) | $ 17.4 | |||
| Intrinsic value of options exercised during the period | $ 2,900 | 2,300 | ||
| Unrecognized compensation cost related to unvested stock options | 7,200 | $ 7,200 | ||
| Weighted average recognition period (in years) | 2 years 10 months 24 days | |||
| Restricted stock units | ||||
| Stock-Based Compensation | ||||
| Weighted average recognition period (in years) | 2 years 9 months 18 days | |||
| Stock-based compensation expense | 1,500 | $ 1,600 | $ 4,500 | $ 5,200 |
| Unrecognized compensation expense | $ 12,300 | $ 12,300 | ||
| 2018 Plan | Employee Stock Option | ||||
| Stock-Based Compensation | ||||
| Shares available for future awards (in shares) | 4,765,586 | 4,765,586 | ||
| X | ||||||||||
- Definition Amount of cost not yet recognized for nonvested award under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of cost to be recognized for option under share-based payment arrangement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of noncash expense for share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The grant-date intrinsic value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|